Advisors Asset Management Inc. Grows Stock Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Advisors Asset Management Inc. lifted its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 2.9% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 30,442 shares of the biotechnology company’s stock after purchasing an additional 850 shares during the period. Advisors Asset Management Inc.’s holdings in Axon Enterprise were worth $12,165,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of AXON. PFG Investments LLC increased its position in shares of Axon Enterprise by 0.6% in the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock valued at $1,547,000 after purchasing an additional 25 shares during the last quarter. Gladstone Institutional Advisory LLC increased its holdings in Axon Enterprise by 1.6% in the third quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock valued at $656,000 after buying an additional 26 shares during the last quarter. Mather Group LLC. increased its holdings in Axon Enterprise by 3.7% in the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after buying an additional 27 shares during the last quarter. CWM LLC increased its holdings in Axon Enterprise by 1.3% in the third quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock valued at $1,141,000 after buying an additional 36 shares during the last quarter. Finally, SPC Financial Inc. raised its stake in Axon Enterprise by 2.2% in the third quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company’s stock valued at $708,000 after buying an additional 38 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $610.20 on Wednesday. The business has a 50 day simple moving average of $448.52 and a 200-day simple moving average of $361.95. Axon Enterprise, Inc. has a 12 month low of $224.16 and a 12 month high of $624.84. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The stock has a market capitalization of $46.53 billion, a PE ratio of 157.67, a price-to-earnings-growth ratio of 15.05 and a beta of 0.94.

Insiders Place Their Bets

In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of the stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the transaction, the president now owns 208,166 shares in the company, valued at approximately $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Patrick W. Smith sold 70,000 shares of the firm’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $362.21, for a total value of $25,354,700.00. Following the completion of the sale, the chief executive officer now directly owns 2,945,366 shares of the company’s stock, valued at approximately $1,066,841,018.86. This trade represents a 2.32 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 410,556 shares of company stock worth $161,192,754. 5.70% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research analysts have recently issued reports on AXON shares. Robert W. Baird upped their price objective on Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Needham & Company LLC raised their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Northland Securities increased their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Barclays boosted their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research report on Wednesday, August 7th. Finally, JMP Securities raised their price objective on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a report on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $427.83.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.